ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CRDF Cardiff Oncology Inc

4.08
-0.09 (-2.16%)
After Hours
Last Updated: 18:36:13
Delayed by 15 minutes

Period:

Draw Mode:

Volume 343,293
Bid Price 4.08
Ask Price 4.29
News -
Day High 4.38

Low
0.94

52 Week Range

High
6.42

Day Low 4.09
Company Name Stock Ticker Symbol Market Type
Cardiff Oncology Inc CRDF NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.09 -2.16% 4.08 18:36:13
Open Price Low Price High Price Close Price Prev Close
4.17 4.09 4.38 4.18 4.17
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
4,313 343,293 $ 4.20 $ 1,442,211 - 0.94 - 6.42
Last Trade Time Type Quantity Stock Price Currency
18:15:50 5 $ 4.30 USD

Cardiff Oncology Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
53.17M 44.68M - 488k -41.47M -0.93 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Cardiff Oncology News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No CRDF Message Board. Create One! See More Posts on CRDF Message Board See More Message Board Posts

Historical CRDF Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week4.574.864.064.36689,523-0.49-10.72%
1 Month5.446.384.065.29966,996-1.36-25.00%
3 Months1.556.421.443.831,978,1102.53163.23%
6 Months1.016.420.943.611,003,9973.07303.96%
1 Year1.556.420.942.89820,3632.53163.23%
3 Years8.8010.240.943.78732,096-4.72-53.64%
5 Years3.7025.500.7015.83857,4810.3810.27%

Cardiff Oncology Description

Cardiff Oncology Inc is a clinical-stage, biotechnology company, developing treatment options for cancer patients in indications with the greatest medical need, including KRAS-mutated metastatic colorectal cancer, pancreatic cancer, metastatic castrate-resistant prostate cancer and leukemias.

Your Recent History

Delayed Upgrade Clock